Viewing Study NCT02582632


Ignite Creation Date: 2025-12-24 @ 9:44 PM
Ignite Modification Date: 2026-01-20 @ 11:51 AM
Study NCT ID: NCT02582632
Status: COMPLETED
Last Update Posted: 2021-07-30
First Post: 2015-10-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults
Sponsor: AbbVie
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-11-24
Start Date Type: None
Primary Completion Date: 2016-08-24
Primary Completion Date Type: ACTUAL
Completion Date: 2016-12-01
Completion Date Type: ACTUAL
First Submit Date: 2015-10-20
First Submit QC Date: None
Study First Post Date: 2015-10-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2017-11-16
Results First Submit QC Date: None
Results First Post Date: 2017-12-13
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-07-28
Last Update Post Date: 2021-07-30
Last Update Post Date Type: ACTUAL